Compounds for imaging tau proteins that accumulate in the brain
The present invention provides a compound represented by the following formula (I), a pharmaceutically acceptable salt thereof, or a solvate thereof. wherein: R 1 and R 2 are each separately selected from the group consisting of hydrogen, alkyl, alkenyl, acyl, and hydroxyalkyl; R 3 is hydrogen or halogen; ring A is a benzene ring or a pyridine ring; ring B is selected from the group consisting of the following formulas (i), (ii), (iii), and (iv): in the formula (ii), R a is alkyl; R 4 and R 5 are each separately selected from the group consisting of hydrogen, hydroxy, alkoxy, haloalkoxy, halohydroxyalkoxy, and aminoalkyl; and [Formula 3] represents a double bond or a triple bond. The above compound can be used as a molecular probe for imaging tau proteins that accumulate in the brain.
1. A compound selected from the following:
or a pharmaceutically acceptable salt thereof, or a solvate thereof.
2. The compound of claim 1 , wherein one or more atoms are a radioisotope of the atom or atoms.
3. A composition comprising the compound of claim 1 , or a pharmaceutically acceptable salt thereof, or a solvate thereof, and a pharmaceutically acceptable carrier.
4. A method of tau imaging, comprising:
(a) administering an effective dose of the compound of claim 1 , or a pharmaceutically acceptable salt thereof, or a solvate thereof, to a mammal; and
(b) imaging the brain of the mammal.